We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $201M
1-Year Est. Return 21.29%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$186M
AUM Growth
+$18.5M
Cap. Flow
+$2.6M
Cap. Flow %
1.4%
Top 10 Hldgs %
16.33%
Holding
136
New
11
Increased
60
Reduced
52
Closed
4

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$1.08M
2
BMY icon
Bristol-Myers Squibb
BMY
+$609K
3
MDLZ icon
Mondelez International
MDLZ
+$556K
4
SJM icon
J.M. Smucker
SJM
+$419K
5
UL icon
Unilever
UL
+$405K

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Healthcare 17.44%
3 Industrials 14.91%
4 Consumer Discretionary 13.06%
5 Consumer Staples 12.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$3.9M 2.1%
29,352
-37
-0.1% -$4.45K
AMZN icon
2
Amazon
AMZN
$2.5T
$3.41M 1.84%
20,960
-380
-2% -$60.6K
TMO icon
3
Thermo Fisher Scientific
TMO
$211B
$3.08M 1.66%
6,621
-418
-6% -$196K
DIS icon
4
Walt Disney
DIS
$165B
$3M 1.62%
16,574
+105
+0.6% +$15.1K
COST icon
5
Costco
COST
$415B
$2.98M 1.61%
7,912
-169
-2% -$63.1K
SYK icon
6
Stryker
SYK
$127B
$2.87M 1.55%
11,725
+34
+0.3% +$7.7K
DHR icon
7
Danaher
DHR
$135B
$2.79M 1.51%
14,187
-944
-6% -$189K
V icon
8
Visa
V
$677B
$2.78M 1.5%
12,718
-33
-0.3% -$6.75K
BALL icon
9
Ball Corp
BALL
$17B
$2.76M 1.48%
29,581
-757
-2% -$70K
NKE icon
10
Nike
NKE
$61.9B
$2.73M 1.47%
19,315
-1,779
-8% -$236K
ITW icon
11
Illinois Tool Works
ITW
$81.4B
$2.73M 1.47%
13,386
-85
-0.6% -$17.4K
MSFT icon
12
Microsoft
MSFT
$2.84T
$2.72M 1.46%
12,224
+11
+0.1% +$2.37K
CHD icon
13
Church & Dwight Co
CHD
$23.1B
$2.59M 1.4%
29,736
+120
+0.4% +$10.6K
FISV
14
Fiserv Inc
FISV
$27.2B
$2.59M 1.4%
22,768
+156
+0.7% +$16.8K
EW icon
15
Edwards Lifesciences
EW
$47.6B
$2.55M 1.38%
27,992
+618
+2% +$51.3K
PG icon
16
Procter & Gamble
PG
$343B
$2.48M 1.34%
17,813
+299
+2% +$41.8K
APH icon
17
Amphenol
APH
$188B
$2.47M 1.33%
75,668
-1,288
-2% -$39.6K
GWW icon
18
W.W. Grainger
GWW
$65.3B
$2.44M 1.31%
5,974
-31
-0.5% -$12.2K
WMT icon
19
Walmart Inc
WMT
$871B
$2.44M 1.31%
50,727
+27
+0.1% +$1.31K
PEP icon
20
PepsiCo
PEP
$186B
$2.43M 1.31%
16,374
+118
+0.7% +$16.8K
CTSH icon
21
Cognizant
CTSH
$21.5B
$2.4M 1.29%
29,262
-152
-0.5% -$11.6K
EXPD icon
22
Expeditors International
EXPD
$22.9B
$2.39M 1.29%
25,167
+497
+2% +$45.3K
ECL icon
23
Ecolab
ECL
$75.6B
$2.37M 1.28%
10,943
+215
+2% +$44.9K
PYPL icon
24
PayPal
PYPL
$49.5B
$2.35M 1.27%
10,055
-831
-8% -$172K
ORCL icon
25
Oracle
ORCL
$331B
$2.34M 1.26%
36,211
+99
+0.3% +$5.89K

Similar funds

Eads & Heald Wealth Management's Q4 2020 Portfolio in Review

As of Q4 2020, Eads & Heald Wealth Management held 136 positions worth $186M, up 11% from $167M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Eads & Heald Wealth Management's Q4 2020 filing shows 11 new, 60 increased, 52 reduced and 4 closed positions. Its largest new stake was Salesforce: 4,449 shares worth $990K. The largest sale was Unilever NV New York Registry Shares, an estimated $370K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Eads & Heald Wealth Management's largest Q4 2020 buy was Salesforce: 4,449 shares worth $990K.
  • Eads & Heald Wealth Management added most to Bristol-Myers Squibb in Q4 2020, an estimated $609K increase.
  • Eads & Heald Wealth Management's biggest Q4 2020 reduction was Idexx Laboratories, cutting an estimated $269K.
  • Eads & Heald Wealth Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $370K.
  • Eads & Heald Wealth Management's ten largest holdings make up 16% of its $186M portfolio in Q4 2020.
  • Eads & Heald Wealth Management opened 11 new positions and closed 4 in Q4 2020.
  • Eads & Heald Wealth Management's portfolio value rose 11% quarter-over-quarter to $186M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2020, filed 2 Feb 2021.